Prof. Teresa Trenkwalder is a senior attending physician in the Department of Cardiology at TUM University Hospital, German Heart Center Munich. Clinically, she specialises in non-invasive cardiology, with a focus on echocardiographic imaging as well as the diagnosis and treatment of cardiomyopathies and heart failure. Her research focuses on the genetics and treatment of structural heart disease, particularly cardiomyopathies and amyloidosis.

Prof. Teresa Trenkwalder has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Speaker and travel grants: Pfizer, Alnylam, Zoll, Novartis, AstraZeneca, Alexion, Bayer, Bristol Myers Squibb, Zoll, Boehringer Ingelheim, GE HealthCare and Edwards.